-
961
-
962
Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting‐Induced Proteolysis
منشور في 2025"…The absence of LAT2 led to increased intramuscular glutamine (Gln) accumulation (6.3‐fold, <i>p</i> < 0.0001), accompanied by a reduction in skeletal muscle proteolysis during fasting (0.61‐fold, <i>p</i> = 0.0004) primarily due to decreased proteasomal and autophagic activity (0.45‐fold, <i>p</i> = 0.016 and 0.7‐fold, <i>p</i> = 0.002, respectively). …"
-
963
-
964
-
965
-
966
-
967
Polarimetric SAR Speckle Reduction by Hybrid Iterative Filtering
منشور في 2020احصل على النص الكامل
article -
968
-
969
-
970
Architectural Design Standards for Muslims Prayer Facilities in Airports
منشور في 2010احصل على النص الكامل
article -
971
An Introduction to Reactive Power Compensation for Wind Farms
منشور في 2005احصل على النص الكامل
article -
972
-
973
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
منشور في 2021"…From 1990 to 2019, the absolute number of incident strokes increased by 70·0% (67·0–73·0), prevalent strokes increased by 85·0% (83·0–88·0), deaths from stroke increased by 43·0% (31·0–55·0), and DALYs due to stroke increased by 32·0% (22·0–42·0). During the same period, age-standardised rates of stroke incidence decreased by 17·0% (15·0–18·0), mortality decreased by 36·0% (31·0–42·0), prevalence decreased by 6·0% (5·0–7·0), and DALYs decreased by 36·0% (31·0–42·0). …"
-
974
-
975
-
976
-
977
-
978
-
979
-
980
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans
منشور في 2021"…Together with artificial intelligence-driven in silico and in vitro screening, this C. elegans model identified five compounds that reduced motor dysfunction induced by α-synuclein. Three of these compounds also decreased α-synuclein oligomers in mammalian neurons, including rifabutin which has not been previously investigated for Parkinson’s disease. …"